Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Annals of the Rheumatic Diseases|November 22, 2014
Rsk2 controls synovial fibroblast hyperplasia and the course of arthritisAnja Derer, Christina Böhm, Bettina Grötsch, et al.
Plos Genetics|January 23, 2016
In Vivo Analysis of Disease-Associated Point Mutations Unveils Profound Differences in mRNA Splicing of Peripherin-2 in Rod and Cone PhotoreceptorsElvir Becirovic, Sybille Böhm, Ong Nam Phuong Nguyen, et al.
Science Advances|September 3, 2020
A gene therapy for inherited blindness using dCas9-VPR-mediated transcriptional activationSybille Böhm, Victoria Splith, Lisa Maria Riedmayr, et al.
Nature Communications|October 18, 2023
mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapyLisa Maria Riedmayr, Klara Sonnie Hinrichsmeyer, Stefan Bernhard Thalhammer, et al.
Nature Immunology|November 8, 2016
Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune diseaseRené Pfeifle, Tobias Rothe, Natacha Ipseiz, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2024
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozolePeter A Fasching, Carolin C Hack, Naiba Nabieva, et al.
Geburtshilfe Und Frauenheilkunde|February 12, 2024
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace StudyCarolin C Hack, Nicolai Maass, Bahriye Aktas, et al.
International Journal of Cancer|July 11, 2025
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trialMilena Beierlein, Lothar Häberle, Naiba Nabieva, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 2024
Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace StudyCarolin C Hack, Nicolai Maass, Bahriye Aktas, et al.
Pageof 2